BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

812 related articles for article (PubMed ID: 8669878)

  • 1. The additive effect of peripheral blood stem cells, harvested with low-dose cyclophosphamide, to autologous bone marrow reinfusion on hematopoietic reconstitution after ablative chemotherapy in breast cancer patients with localized disease.
    de Graaf H; Mulder NH; Willemse PH; van der Graaf WT; Sleijfer DT; Zijlstra JG; Elias M; Sibinga CT; Vellenga E; de Vries EG
    Anticancer Res; 1995; 15(6B):2851-6. PubMed ID: 8669878
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Accelerated hemopoietic recovery after chemotherapy and autologous bone marrow transplantation in hematological malignancies using recombinant GM-CSF: preliminary results obtained in 14 cases.
    Visani G; Tosi P; Gamberi B; Cenacchi A; Mazzanti P; Stabilini C; Bandini G; Mazza P; Gherlinzoni F; Cavo M
    Haematologica; 1990; 75(6):551-4. PubMed ID: 2098298
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hemopoietic reconstitution after repeated autologous transplantation with mafosfamide-purged marrow.
    Beaujean F; Hartmann O; Benhamou E; Lemerle J; Duedari N
    Bone Marrow Transplant; 1989 Sep; 4(5):537-41. PubMed ID: 2790332
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of malignant lymphomas with very-high-dose CVB followed by transplantation of autologous blood stem cells collected after mobilizing chemotherapy.
    Majolino I; Scimè R; Indovina A; Vasta S; Patti C; Gentile S; Santoro A; Di Noto R; Fabbiano F; Guarnaccia C
    Haematologica; 1991 Mar; 76 Suppl 1():66-71. PubMed ID: 1713875
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [High-dose adjuvant chemotherapy with peripheral blood stem cell transplantation for breast cancer with poor prognosis--a pilot study].
    Maruyama F; Ezaki K; Miyazaki H; Wakita M; Maeda H; Nomura T; Tsuzuki M; Sobue R; Okamoto M; Matsui T
    Gan To Kagaku Ryoho; 1992 Sep; 19(11):1859-65. PubMed ID: 1381571
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acceleration of hemopoietic recovery after autologous bone marrow transplantation by low doses of peripheral blood stem cells.
    Lopez M; Mortel O; Pouillart P; Zucker JM; Fechtenbaum J; Douay L; Palangie T; Michon J; Salmon D; Gorin NC
    Bone Marrow Transplant; 1991 Mar; 7(3):173-81. PubMed ID: 1676321
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Successful autologous transplantation of blood stem cells mobilized with recombinant human granulocyte-macrophage colony-stimulating factor.
    Haas R; Ho AD; Bredthauer U; Cayeux S; Egerer G; Knauf W; Hunstein W
    Exp Hematol; 1990 Feb; 18(2):94-8. PubMed ID: 1968009
    [TBL] [Abstract][Full Text] [Related]  

  • 8. GM-CSF therapy for delayed engraftment after autologous bone marrow transplantation.
    Brandwein JM; Nayar R; Baker MA; Sutton DM; Scott JG; Sutcliffe SB; Keating A
    Exp Hematol; 1991 Mar; 19(3):191-5. PubMed ID: 1995310
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [A study to overcome drug resistance using high-dose chemotherapy with autologous bone marrow transplantation].
    Mukaiyama T; Ogawa M; Horikoshi N; Inoue K; Fukutani H; Tabata M; Hirano A; Mizunuma N; Itami S
    Gan To Kagaku Ryoho; 1989 May; 16(5):2013-8. PubMed ID: 2471462
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Autologous hematopoietic stem cell transplantation--application to recurrent breast cancer].
    Mukaiyama T; Ogawa M
    Gan To Kagaku Ryoho; 1990 Oct; 17(10):1989-96. PubMed ID: 1699496
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heterogeneity of circulating hematopoietic progenitors in cancer patients treated with high-dose cyclophosphamide and recombinant human granulocyte macrophage colony stimulating factor (rhGM-CSF).
    Siena S; Bregni M; Ravagnani F; Brando B; Tarella C; Bonadonna G; Gianni AM
    Haematologica; 1990; 75 Suppl 1():6-10. PubMed ID: 2190884
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mobilization of peripheral blood progenitor cells by chemotherapy and granulocyte-macrophage colony-stimulating factor for hematologic support after high-dose intensification for breast cancer.
    Elias AD; Ayash L; Anderson KC; Hunt M; Wheeler C; Schwartz G; Tepler I; Mazanet R; Lynch C; Pap S
    Blood; 1992 Jun; 79(11):3036-44. PubMed ID: 1350229
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Durable and complete hematopoietic reconstitution after autografting of rhGM-CSF exposed peripheral blood progenitor cells.
    Gianni AM; Tarella C; Siena S; Bregni M; Boccadoro M; Lombardi F; Bengala C; Bonadonna G; Pileri A
    Bone Marrow Transplant; 1990 Aug; 6(2):143-5. PubMed ID: 1976399
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Utilization of recombinant human GM-CSF to enhance peripheral progenitor cell yield for autologous transplantation.
    Ho AD; Haas R; Korbling M; Dietz M; Hunstein W
    Bone Marrow Transplant; 1991; 7 Suppl 1():13-7. PubMed ID: 1675138
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The use of recombinant human granulocyte-macrophage colony stimulating factor for the treatment of delayed engraftment following high dose therapy and autologous hematopoietic stem cell transplantation for lymphoid malignancies.
    Vose JM; Bierman PJ; Kessinger A; Coccia PF; Anderson J; Oldham FB; Epstein C; Armitage JO
    Bone Marrow Transplant; 1991 Feb; 7(2):139-43. PubMed ID: 1675592
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High dose chemotherapy with cisplatin, VP16 and carboplatin with stem cell support in patients with advanced ovarian cancer.
    Pierelli L; Menichella G; Foddai ML; Serafini R; Vittori M; Paoloni A; Benedetti Panici P; Scambia G; Baiocchi G; Greggi S
    Haematologica; 1991 Mar; 76 Suppl 1():63-5. PubMed ID: 1677915
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Difference in kinetics of hematopoietic reconstitution between ALL and ANLL after autologous bone marrow transplantation with marrow treated in vitro with mafosfamide (ASTA Z 7557).
    Douay L; Laporte JP; Mary JY; Lopez M; Lemonnier MP; Stachowiak J; Benitez O; Deloux J; Najman A; Salmon C
    Bone Marrow Transplant; 1987 Jun; 2(1):33-43. PubMed ID: 3332155
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [High-dose cyclophosphamide, thio-TEPA, etoposide with autologous bone marrow transplantation for refractory cancers].
    Mukaiyama T; Ogawa M; Horikoshi N; Inoue K; Hirano A; Mizunuma N; Matsuoka A; Matsumura T
    Gan To Kagaku Ryoho; 1990 Nov; 17(11):2207-11. PubMed ID: 2122810
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peripheral blood-derived stem cell collections for use in autologous transplantation after high dose chemotherapy: an alternative approach.
    Williams SF; Bitran JD; Richards JM; DeChristopher PJ; Barker E; Conant J; Golomb HM; Orlina AR
    Bone Marrow Transplant; 1990 Feb; 5(2):129-33. PubMed ID: 1968775
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The hematopoietic growth factor GM-CSF in chemotherapy for advanced breast carcinoma].
    Hoekman K; Wagstaff J; Boven E; van Groeningen CJ; Vermorken JB; Pinedo HM
    Ned Tijdschr Geneeskd; 1991 Mar; 135(10):415-9. PubMed ID: 2020313
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 41.